AI assistant
Sending…
HEALTHSTREAM INC — Director's Dealing 2013
May 21, 2013
32355_dirs_2013-05-21_c839d5f6-4cd1-4f5b-b993-1a3a0b126c26.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HEALTHSTREAM INC (HSTM)
CIK: 0001095565
Period of Report: 2013-05-17
Reporting Person: MCLAREN JEFFREY L (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-05-17 | Common Stock | M | 7267 | $2.45 | Acquired | 20734 | Direct |
| 2013-05-17 | Common Stock | S | 7267 | $25.00 | Disposed | 13467 | Direct |
| 2013-05-20 | Common Stock | M | 2733 | $2.45 | Acquired | 16200 | Direct |
| 2013-05-20 | Common Stock | S | 2733 | $25.0513 | Disposed | 13467 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-05-17 | Employee Stock Option (right to buy) | $2.45 | M | 5000 | Disposed | 2017-05-28 | Common Stock (5000) | Direct |
| 2013-05-17 | Employee Stock Option (right to buy) | $2.45 | M | 2267 | Disposed | 2017-05-28 | Common Stock (2267) | Direct |
| 2013-05-20 | Employee Stock Option (right to buy) | $2.45 | M | 2733 | Disposed | 2017-05-28 | Common Stock (2733) | Direct |
Footnotes
F1: The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on March 21, 2013.
F2: This transaction was executed in multiple trades at prices ranging from $25.00 to $25.115. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
More from HEALTHSTREAM INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 29
Regulatory Filings
2026
May 8
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 4
Annual Report
2026
Apr 10
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27